Skip to main navigation Skip to search Skip to main content

mHSPC-Therapie mit Apalutamid/ADT

Translated title of the contribution: Metastatic hormone-sensitive prostate cancer (mHSPC) therapy with apalutamide/ADT

Ekkehardt Bismarck, Peter Hammerer, Axel S. Merseburger, Andres Jan Schrader

Translated title of the contributionMetastatic hormone-sensitive prostate cancer (mHSPC) therapy with apalutamide/ADT
Original languageGerman
JournalOncology Research and Treatment
Volume43
Pages (from-to)6-12
Number of pages7
ISSN2296-5270
DOIs
Publication statusPublished - 01.05.2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

DFG Research Classification Scheme

  • 2.22-14 Hematology, Oncology
  • 2.22-08 Pharmacy
  • 2.22-23 Reproductive Medicine, Urology

Cite this